AzTrials
AzTrials

Condition

Insulin Resistance Clinical Trials

Studies of insulin resistance, matched by condition name and medical subject headings. Start with those open to enrolment.

2,996 registered studies

In numbers

Open to volunteers
300
Active
376
With results posted
412
All registered
2,996

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 300
  • Obesity, Childhood, Insulin Resistance

    Fiber and Metformin Combination Therapy in Adolescents With Severe Obesity and Insulin Resistance

    • Recruiting
    • Age: 12 to 18 years
    • Phase 3
    • Pill or oral medicine

    This is a 12-month, single center, three-arm parallel design, double-blind, randomized clinical trial, to compare the effects of supplemental dietary fiber and metformin (MET) alone and in combination over 12 months on glucose…

    Trial name
    NCT04578652
    Testing
    Metformin 850 mg oral tablet bid, Supplemental fiber mixture (35 g total) composed of 6g of Oligofructose + 12g of resistant maltodextrin + 12g of acacia gum + 5g of PGX.
    Where
    Canada
    Volunteers
    90 people
    Sponsor
    University of Alberta
    Can I take part? NCT04578652
  • Insulin Resistance, Obesity

    Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity

    • Not yet recruiting
    • Age: 18 to 65 years
    • Phase 2
    • Pill or oral medicine

    Background: Obesity and related illnesses cause at least 2.8 million deaths each year worldwide. Few treatments exist for obesity that are safe and widely available.

    Trial name
    NCT05713799
    Testing
    Alpha-lipoic acid, Mirabegron
    Where
    United States
    Volunteers
    60 people, healthy volunteers welcome
    Sponsor
    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
    Can I take part? NCT05713799
  • Healthy Volunteer

    Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults 55 >= Years Old: A Randomized Triple-Masked Controlled Clinical Trial

    • Recruiting
    • Age: 55 to 100 years
    • Pill or oral medicine

    Background: As people age, the cells in the pancreas that produce insulin begin to release less of this hormone, and levels of blood glucose (sugar) rise. This can lead to illnesses such as diabetes.

    Trial name
    NCT06274749
    Testing
    Urolithin A
    Where
    United States
    Volunteers
    180 people
    Sponsor
    National Institute on Aging (NIA)
    Can I take part? NCT06274749
  • Obesity, Overweight

    Improving Glycemic Control With Electrical Stimulation

    • Recruiting
    • Age: 18 years and older
    • Medical device

    Once written consent is obtained, the participant will be provided with an accelerometer to be worn for 7 days to assess current physical activity levels.

    Conditions
    Obesity, Overweight, Insulin Resistance
    Trial name
    NCT03947697
    Testing
    Neuromuscular Electrical Stimulation (Sensory), Neuromuscular Electrical Stimulation, Resistance Training
    Where
    United States
    Volunteers
    60 people, healthy volunteers welcome
    Sponsor
    University of Texas, El Paso
    Can I take part? NCT03947697
  • Insulin Resistance

    Neuromuscular Electrical Stimulation: A Novel Treatment for Improving Metabolism

    • Recruiting
    • Age: 18 to 65 years
    • Medical device

    Once written consent is obtained, the participant will be provided with an accelerometer to be worn for 7 days to assess current physical activity levels.

    Trial name
    NCT06722391
    Testing
    Neuromuscular Electrical Stimulation (Sensory), Neuromuscular Electrical Stimulation, Resistance Training
    Where
    United States
    Volunteers
    80 people, healthy volunteers welcome
    Sponsor
    University of Texas, El Paso
    Can I take part? NCT06722391
  • Obesity & Overweight

    IGOB131 As A GLP-1 Modulator For Metabolic Disorders In Adults With Obesity

    • Not yet recruiting
    • Age: 18 to 65 years
    • Phase 2
    • Pill or oral medicine

    This clinical trial will investigate the effect of standardized Irvingia gabonensis extract (IGOB131) on GLP-1 dynamics, DPP-4 activity, metabolic parameters, and inflammatory markers in adults with obesity.

    Trial name
    NCT07884058
    Testing
    IGOB131, Dextrin
    Volunteers
    80 people
    Sponsor
    University of Yaounde 1
    Can I take part? NCT07884058
  • Asthma, Atherosclerosis

    Study of the Effect of Innate on the Inflammatory Response to Endotoxin

    • Recruiting
    • Age: 18 to 100 years
    • Observational study

    Background: Innate immunity is the process by which white blood cells and other parts of the immune system sense and respond to potential infections by causing an inflammation.

    Conditions
    Asthma, Atherosclerosis, Metabolic Syndrome, Insulin Resistance
    Trial name
    NCT01143480
    Where
    United States
    Volunteers
    725 people, healthy volunteers welcome
    Sponsor
    National Institute of Environmental Health Sciences (NIEHS)
    Can I take part? NCT01143480
  • PCOS (Polycystic Ovary Syndrome), Insulin Resistance

    Inositol and Metformin Administration in Mediterranean Diet and Low-Carbohydrate Diets in Women With PCOS

    • Recruiting
    • Age: 20 to 40 years
    • Pill or oral medicine

    Polycystic ovary syndrome (PCOS) is a common endocrine disorder frequently associated with obesity, insulin resistance (IR), and metabolic dysfunction.

    Conditions
    PCOS (Polycystic Ovary Syndrome), Insulin Resistance, Obesity (BMI>30)
    Trial name
    NCT07770711
    Testing
    Metformin, İnositol, Folic Acid
    Where
    Turkey (Türkiye)
    Volunteers
    90 people
    Sponsor
    Dicle University
    Can I take part? NCT07770711
  • Type 2 Diabetes, Insulin Resistance

    Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents

    • Recruiting
    • Age: 14 to 18 years
    • Observational study

    This research study collects health-related information and blood samples to better understand how body composition, lifestyle habits, and diet influence meta-inflammatory monocytes (MiMos) in adolescents.

    Conditions
    Type 2 Diabetes, Insulin Resistance, Obesity, Metabolic Disease
    Trial name
    NCT06007404
    Where
    United States
    Volunteers
    175 people, healthy volunteers welcome
    Sponsor
    University of Michigan
    Can I take part? NCT06007404
  • Obesity (BMI>30), Insulin Resistance

    Interplay of Central and Peripheral Vascular Effects of Insulin in Obesity

    • Not yet recruiting
    • Age: 18 to 65 years
    • Early Phase 1

    Determine the impact of obesity with insulin resistance on the neurovascular response to brain insulin stimulation.

    Trial name
    NCT07653464
    Testing
    human insulin
    Where
    United States
    Volunteers
    64 people, healthy volunteers welcome
    Sponsor
    University of Missouri-Columbia
    Can I take part? NCT07653464

Completed, with results posted

All –
  • Obesity, Type2diabetes

    The Effects of Glucagon on Hepatic Metabolism

    • Completed
    • Age: 25 to 65 years
    • Phase 1/2
    • Results posted

    Whether impaired postprandial glucagon suppression in prediabetes and T2DM is an attempt to overcome resistance to glucagon's actions on hepatic AA catabolism, a defect in α-cell function, or a combination of both are important…

    Conditions
    Obesity, Type2diabetes, NAFLD
    Trial name
    NCT05500586
    Testing
    Glucagon response study
    Where
    United States
    Volunteers
    21 people, healthy volunteers welcome
    Sponsor
    Adrian Vella
    Can I take part? NCT05500586
  • Hyperinsulinemia, Insulin Resistance

    Glycemic Effect of Diazoxide in NAFLD

    • Completed
    • Age: 18 to 70 years
    • Phase 1
    • Pill or oral medicine
    • Medical device
    • Results posted

    The goal of this clinical trial is to compare a two-week course of diazoxide (at two different doses) and placebo in people with overweight/obesity and insulin resistance (IR) with, or at high risk for, non-alcoholic fatty liver…

    Conditions
    Hyperinsulinemia, Insulin Resistance, Non-Alcoholic Fatty Liver Disease, Prediabetic State
    Trial name
    NCT05729282
    Testing
    Diazoxide oral suspension, 1 mg per kg per dose, Diazoxide oral suspension, 2 mg per kg per dose, FreeStyle Libre Pro
    Where
    United States
    Volunteers
    22 people
    Sponsor
    Columbia University
    Can I take part? NCT05729282
  • Continuous Glucose Monitoring, Oral Glucose Tolerance

    Non-Nutritive Sweetener Consumption and Glucose Homeostasis in Older Adults With Prediabetes

    • Completed
    • Age: 40 years and older
    • Results posted

    Animal and observational research in humans suggest that specific types of non-nutritive sweeteners (NNS) may impair glycemic control.

    Conditions
    Continuous Glucose Monitoring, Oral Glucose Tolerance, Insulin Sensitivity, Inflammatory Markers
    Trial name
    NCT05337098
    Testing
    Non-Nutritive Sweetener Intake and impact on glucose homeostasis
    Where
    United States
    Volunteers
    31 people
    Sponsor
    Virginia Polytechnic Institute and State University
    Can I take part? NCT05337098
  • Insulin Resistance

    The Suppression of Toll Like Receptors by Insulin

    • Completed
    • Age: 20 to 65 years
    • Injection or infusion
    • Results posted

    This study will help us understand the possible beneficial effects of insulin in inflammation. Inflamamtion is considered to be the cause of atherosclerosis and heart disease.

    Trial name
    NCT01151605
    Testing
    insulin infusion, Dextrose infusion, Saline Infusion
    Where
    United States
    Volunteers
    42 people, healthy volunteers welcome
    Sponsor
    University at Buffalo
    Can I take part? NCT01151605
  • Hyperglycemia, Hyperlipidemia

    Healthy Volunteers Study of the Effects of Olanzapine and Ziprasidone

    • Completed
    • Age: 18 to 45 years
    • Injection or infusion
    • Results posted

    Primary Aim: To test the acute effects of olanzapine or ziprasidone administration, in comparison to placebo, on insulin sensitivity in antipsychotic-naïve healthy young men, measured as whole-body dextrose infusion rates…

    Trial name
    NCT00910988
    Testing
    Olanzapine, Ziprasidone
    Where
    United States
    Volunteers
    46 people, healthy volunteers welcome
    Sponsor
    Washington University School of Medicine

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in